Clinical trial
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study: Multi-center, Prospective, Observational, Post-Market Follow-up Study
NCT05639569 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study: Multi-center, Prospective, Observational, Post-Market Follow-up Study
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 3, 2023
- Completion date
- December 30, 2030
- Enrollment
- 147 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
aneurysm thoracic, dissection of thoracic aorta